KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Change in Acquisitions & Divestments (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Change in Acquisitions & Divestments for 16 consecutive years, with $734.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 21.56% to $734.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $793.6 million, a 28.25% decrease, with the full-year FY2025 number at $793.6 million, down 28.25% from a year prior.
  • Change in Acquisitions & Divestments was $734.6 million for Q4 2025 at Bio-Rad Laboratories, up from -$386.6 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $936.5 million in Q4 2024 to a low of -$386.6 million in Q3 2025.
  • A 5-year average of $155.0 million and a median of $102.5 million in 2022 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: surged 4596.82% in 2022, then tumbled 519.8% in 2024.
  • Bio-Rad Laboratories' Change in Acquisitions & Divestments stood at $285.9 million in 2021, then crashed by 164.66% to -$184.8 million in 2022, then skyrocketed by 230.41% to $241.1 million in 2023, then skyrocketed by 288.51% to $936.5 million in 2024, then decreased by 21.56% to $734.6 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Change in Acquisitions & Divestments are $734.6 million (Q4 2025), -$386.6 million (Q3 2025), and $274.4 million (Q2 2025).